Regents of the University of California Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intellia Therapeutics
NTLA
|
+$169K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OBDC
|
+$60.3M |
| 2 |
Cibus
CBUS
|
+$183K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 63.24% |
| 2 | Healthcare | 0.99% |
| 3 | Consumer Staples | 0.75% |
| 4 | Energy | 0.42% |
| 5 | Materials | 0.35% |
Similar funds
Regents of the University of California's Q4 2023 Portfolio in Review
As of Q4 2023, Regents of the University of California held 28 positions worth $796M, up 2.2% from $779M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Regents of the University of California withdrew a net $60.4M in Q4 2023, closing 1 position and reducing 1 holding. Its most notable exit was Cibus, an estimated $183K position sold in full.
By sector, the portfolio is most concentrated in Financials at 63% of assets, down from 66% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Regents of the University of California added an estimated $169K to Intellia Therapeutics.
- Regents of the University of California added most to Intellia Therapeutics in Q4 2023, an estimated $169K increase.
- Regents of the University of California's biggest Q4 2023 reduction was Blue Owl Capital, cutting an estimated $60.3M.
- Regents of the University of California fully exited Cibus in Q4 2023, selling an estimated $183K.
- Regents of the University of California's ten largest holdings make up 98% of its $796M portfolio in Q4 2023.
- Regents of the University of California opened 0 new positions and closed 1 in Q4 2023.
- Regents of the University of California's portfolio value rose 2.2% quarter-over-quarter to $796M.
Based on Regents of the University of California's 13F filing for Q4 2023, filed 25 Jan 2024.